Open | - |
Close | - |
Volume / Avg. | 11.446K / 3.166M |
Day Range | - - - |
52 Wk Range | 5.300 - 12.150 |
Market Cap | $4.109B |
P/E Ratio | 61.592 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.77% |
Days to Cover | 6.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Grifols (NASDAQ: GRFS) through any online brokerage.
Other companies in Grifols’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Grifols (NASDAQ: GRFS) was reported by Deutsche Bank on Tuesday, March 12, 2024. The analyst firm set a price target for 0.00 expecting GRFS to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Grifols (NASDAQ: GRFS) is $6.05 last updated Today at March 19, 2024 at 8:42 AM EDT.
A quarterly cash dividend of $0.34 per share of Class A Common Stock. The quarterly cash dividend was payable on June 14, 2021 to stockholders of record on June 3, 2021.
Grifols’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Grifols.
Grifols is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.